Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • stockmasterp stockmasterp Jan 28, 2013 2:49 PM Flag

    Zerenex now has a meaningful opportunity to become the first phosphate binder to also have clinical meaningful properties to manage anemia associated with dialysis patients," Roth Capital analyst Joseph Pantginis wrote in a note to clients.

    Zerenex now has a meaningful opportunity to become the first phosphate binder to also have clinical meaningful properties to manage anemia associated with dialysis patients," Roth Capital analyst Joseph Pantginis wrote in a note to clients.

    Sentiment: Strong Buy

 
KERX
5.86-0.34(-5.48%)Jun 24 4:00 PMEDT